Home » anabolic steroids, Anabolic Steroids Labs, Beginners, bodybuilding, Fake Steroids, Steroids Cycles, Steroids Pictures, Steroids Profiles, Steroids Purchase, Steroids Use, Women's bodybuilding

The Anabolic steroids Control Act.

11 March 2011 One Comment

PUBLIC LAW 108–358—OCT. 22, 2004 118 STAT. 1661

 

 

 

Public Law 108–358

108th Congress

An Act

To amend the Controlled Substances Act to clarify the definition of anabolic steroids

and to provide for research and education activities relating to steroids and

steroid precursors.

Be it enacted by the Senate and House of Representatives of

the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the ‘‘Anabolic Steroid Control Act

of 2004’’.

SEC. 2. AMENDMENTS TO THE CONTROLLED SUBSTANCES ACT.

(a) D

(21 U.S.C. 802) is amended—

(1) in paragraph (41)—

(A) by realigning the margin so as to align with paragraph

(40); and

(B) by striking subparagraph (A) and inserting the

following:

‘‘(A) The term ‘anabolic steroid’ means any drug or hormonal

substance, chemically and pharmacologically related to testosterone

(other than estrogens, progestins, corticosteroids, and

dehydroepiandrosterone), and includes—

‘‘(i) androstanediol—

‘‘(I) 3

‘‘(II) 3

‘‘(ii) androstanedione (5

‘‘(iii) androstenediol—

‘‘(I) 1-androstenediol (3

ene);

‘‘(II) 1-androstenediol (3

ene);

‘‘(III) 4-androstenediol (3

ene); and

‘‘(IV) 5-androstenediol (3

ene);

‘‘(iv) androstenedione—

‘‘(I) 1-androstenedione ([5

‘‘(II) 4-androstenedione (androst-4-en-3,17-dione); and

‘‘(III) 5-androstenedione (androst-5-en-3,17-dione);

‘‘(v) bolasterone (7

3-one);

‘‘(vi) boldenone (17

‘‘(vii) calusterone (7

en-3-one);

EFINITIONS.—Section 102 of the Controlled Substances Actβ,17β-dihydroxy-5α-androstane; andα,17β-dihydroxy-5α-androstane;α-androstan-3,17-dione);β,17β-dihydroxy-5α-androst-1-α,17β-dihydroxy-5α-androst-1-β,17β-dihydroxy-androst-4-β,17β-dihydroxy-androst-5-α]-androst-1-en-3,17-dione);α,17α-dimethyl-17β-hydroxyandrost-4-en-β-hydroxyandrost-1,4,-diene-3-one);β,17α-dimethyl-17β-hydroxyandrost-4-21 USC 801 note.

Anabolic Steroid

Control Act of

2004.

Oct. 22, 2004

[S. 2195]

VerDate 11-MAY-2000 04:00 Nov 19, 2004 Jkt 039139 PO 00358 Frm 00001 Fmt 6580 Sfmt 6581 E:\PUBLAW\PUBL358.108 BILLW PsN: PUBL358

118 STAT. 1662 PUBLIC LAW 108–358—OCT. 22, 2004

‘‘(viii) clostebol (4-chloro-17

‘‘(ix) dehydrochloromethyltestosterone (4-chloro-17

hydroxy-17

‘‘(x)

hydroxy-5

‘‘(xi) 4-dihydrotestosterone (17

‘‘(xii) drostanolone (17

one);

‘‘(xiii) ethylestrenol (17

‘‘(xiv) fluoxymesterone (9-fluoro-17

dihydroxyandrost-4-en-3-one);

‘‘(xv) formebolone (2-formyl-17

dihydroxyandrost-1,4-dien-3-one);

‘‘(xvi) furazabol (17

furazan);

‘‘(xvii) 13

‘‘(xviii) 4-hydroxytestosterone (4,17

en-3-one);

‘‘(xix) 4-hydroxy-19-nortestosterone (4,17

en-3-one);

‘‘(xx) mestanolone (17

3-one);

‘‘(xxi) mesterolone (1

3-one);

‘‘(xxii) methandienone (17

dien-3-one);

‘‘(xxiii) methandriol (17

5-ene);

‘‘(xxiv) methenolone (1-methyl-17

en-3-one);

‘‘(xxv) 17

‘‘(xxvi) 17

‘‘(xxvii) 17

‘‘(xxviii) 17

hydroxy-17

‘‘(xxix) methyldienolone (17

4,9(10)-dien-3-one);

‘‘(xxx) methyltrienolone (17

11-trien-3-one);

‘‘(xxxi) methyltestosterone (17

hydroxyandrost-4-en-3-one);

‘‘(xxxii) mibolerone (7

3-one);

‘‘(xxxiii) 17

17

‘‘(xxxiv) nandrolone (17

‘‘(xxxv) norandrostenediol—

‘‘(I) 19-nor-4-androstenediol (3

ene);

‘‘(II) 19-nor-4-androstenediol (3

ene);

‘‘(III) 19-nor-5-androstenediol (3

5-ene); and

‘‘(IV) 19-nor-5-androstenediol (3

5-ene);

‘‘(xxxvi) norandrostenedione—

β-hydroxyandrost-4-en-3-one);βα-methyl-androst-1,4-dien-3-one);>1-dihydrotestosterone (a.k.a. ‘1-testosterone’) (17βα-androst-1-en-3-one);β-hydroxy-androstan-3-one);β-hydroxy-2α-methyl-5α-androstan-3-α-ethyl-17β-hydroxyestr-4-ene);α-methyl-11β,17βα-methyl-11α,17βα-methyl-17β-hydroxyandrostano[2,3-c]-β-ethyl-17α-hydroxygon-4-en-3-one;β-dihydroxy-androst-4-β-dihydroxy-estr-4-α-methyl-17β-hydroxy-5α-androstan-α-methyl-17β-hydroxy-[5α]-androstan-α-methyl-17β-hydroxyandrost-1,4-α-methyl-3β,17β-dihydroxyandrost-β-hydroxy-5α-androst-1-α-methyl-3β, 17β-dihydroxy-5α-androstane;α-methyl-3α,17β-dihydroxy-5α-androstane;α-methyl-3β,17β-dihydroxyandrost-4-ene.α-methyl-4-hydroxynandrolone (17α-methyl-4-β-hydroxyestr-4-en-3-one);α-methyl-17β-hydroxyestra-α-methyl-17β-hydroxyestra-4,9-α-methyl-17βα,17α-dimethyl-17β-hydroxyestr-4-en-α-methyl->1-dihydrotestosterone (17β-hydroxy-α-methyl-5α-androst-1-en-3-one) (a.k.a. ‘17-α-methyl-1-testosterone’);β-hydroxyestr-4-en-3-one);β, 17β-dihydroxyestr-4-α, 17β-dihydroxyestr-4-β, 17β-dihydroxyestr-α, 17β-dihydroxyestr-VerDate 11-MAY-2000 04:00 Nov 19, 2004 Jkt 039139 PO 00358 Frm 00002 Fmt 6580 Sfmt 6581 E:\PUBLAW\PUBL358.108 BILLW PsN: PUBL358

PUBLIC LAW 108–358—OCT. 22, 2004 118 STAT. 1663

‘‘(I) 19-nor-4-androstenedione (estr-4-en-3,17-dione);

and

‘‘(II) 19-nor-5-androstenedione (estr-5-en-3,17-dione;

‘‘(xxxvii) norbolethone (13

en-3-one);

‘‘(xxxviii) norclostebol (4-chloro-17

one);

‘‘(xxxix) norethandrolone (17

3-one);

‘‘(xl) normethandrolone (17

3-one);

‘‘(xli) oxandrolone (17

androstan-3-one);

‘‘(xlii) oxymesterone (17

en-3-one);

‘‘(xliii) oxymetholone (17

hydroxy-[5

‘‘(xliv) stanozolol (17

eno[3,2-c]-pyrazole);

‘‘(xlv) stenbolone (17

3-one);

‘‘(xlvi) testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-

1,4-dien-17-oic acid lactone);

‘‘(xlvii) testosterone (17

‘‘(xlviii) tetrahydrogestrinone (13

hydroxygon-4,9,11-trien-3-one);

‘‘(xlix) trenbolone (17

‘‘(xlx) any salt, ester, or ether of a drug or substance

described in this paragraph.

The substances excluded under this subparagraph may at any time

be scheduled by the Attorney General in accordance with the

authority and requirements of subsections (a) through (c) of section

201.’’; and

(2) in paragraph (44), by inserting ‘‘anabolic steroids,’’ after

‘‘marihuana,’’.

(b) A

201(g) of the Controlled Substances Act (21 U.S.C. 811(g)) is

amended—

(1) in paragraph (1), by striking ‘‘substance from a schedule

if such substance’’ and inserting ‘‘drug which contains a controlled

substance from the application of titles II and III of

the Comprehensive Drug Abuse Prevention and Control Act

(21 U.S.C. 802 et seq.) if such drug’’; and

(2) in paragraph (3), by adding at the end the following:

‘‘(C) Upon the recommendation of the Secretary of Health

and Human Services, a compound, mixture, or preparation

which contains any anabolic steroid, which is intended for

administration to a human being or an animal, and which,

because of its concentration, preparation, formulation or

delivery system, does not present any significant potential for

abuse.’’.

(c) A

Anabolic Steroids Control Act of 1990 (Public Law 101–647) is

amended—

(1) by striking subsection (a); and

(2) by redesignating subsections (b) and (c) as subsections

(a) and (b), respectively.

β,17α-diethyl-17β-hydroxygon-4-β-hydroxyestr-4-en-3-α-ethyl-17β-hydroxyestr-4-en-α-methyl-17β-hydroxyestr-4-en-α-methyl-17β-hydroxy-2-oxa-[5α]-α-methyl-4,17β-dihydroxyandrost-4-α-methyl-2-hydroxymethylene-17βα]-androstan-3-one);α-methyl-17α-hydroxy-[5α]-androst-2-β-hydroxy-2-methyl-[5α]-androst-1-en-β-hydroxyandrost-4-en-3-one);β,17α-diethyl-17ββ-hydroxyestr-4,9,11-trien-3-one); andUTHORITY AND CRITERIA FOR CLASSIFICATION.—SectionNABOLIC STEROIDS CONTROL ACT.—Section 1903 of the21 USC 802 note.

VerDate 11-MAY-2000 04:00 Nov 19, 2004 Jkt 039139 PO 00358 Frm 00003 Fmt 6580 Sfmt 6581 E:\PUBLAW\PUBL358.108 BILLW PsN: PUBL358

118 STAT. 1664 PUBLIC LAW 108–358—OCT. 22, 2004

(d) E

shall take effect 90 days after the date of enactment of this Act.

FFECTIVE DATE.—The amendments made by this sectionSEC. 3. SENTENCING COMMISSION GUIDELINES.

The United States Sentencing Commission shall—

(1) review the Federal sentencing guidelines with respect

to offenses involving anabolic steroids;

(2) consider amending the Federal sentencing guidelines

to provide for increased penalties with respect to offenses

involving anabolic steroids in a manner that reflects the seriousness

of such offenses and the need to deter anabolic steroid

trafficking and use; and

(3) take such other action that the Commission considers

necessary to carry out this section.

SEC. 4. PREVENTION AND EDUCATION PROGRAMS.

(a) I

(referred to in this Act as the ‘‘Secretary’’) shall award grants

to public and nonprofit private entities to enable such entities

to carry out science-based education programs in elementary and

secondary schools to highlight the harmful effects of anabolic

steroids.

(b) E

(1) A

(a), an entity shall prepare and submit to the Secretary an

application at such time, in such manner, and containing such

information as the Secretary may require.

(2) P

the Secretary shall give preference to applicants that intend

to use grant funds to carry out programs based on—

(A) the Athletes Training and Learning to Avoid

Steroids program;

(B) The Athletes Targeting Healthy Exercise and

Nutrition Alternatives program; and

(C) other programs determined to be effective by the

National Institute on Drug Abuse.

(c) U

subsection (a) shall be used for education programs that will directly

communicate with teachers, principals, coaches, as well as

elementary and secondary school children concerning the harmful

effects of anabolic steroids.

(d) A

to be appropriated to carry out this section, $15,000,000 for each

of fiscal years 2005 through 2010.

N GENERAL.—The Secretary of Health and Human ServicesLIGIBILITY.—PPLICATION.—To be eligible for grants under subsectionREFERENCE.—In awarding grants under subsection (a),SE OF FUNDS.—Amounts received under a grant underUTHORIZATION OF APPROPRIATIONS.—There is authorizedSEC. 5. NATIONAL SURVEY ON DRUG USE AND HEALTH.

(a) I

shall ensure that the National Survey on Drug Use and Health

includes questions concerning the use of anabolic steroids.

N GENERAL.—The Secretary of Health and Human Services42 USC

290aa–4 note.

Grants.

42 USC

290bb–25f.

28 USC 994 note.

21 USC 802 note.

VerDate 11-MAY-2000 04:00 Nov 19, 2004 Jkt 039139 PO 00358 Frm 00004 Fmt 6580 Sfmt 6581 E:\PUBLAW\PUBL358.108 BILLW PsN: PUBL358

PUBLIC LAW 108–358—OCT. 22, 2004 118 STAT. 1665

LEGISLATIVE HISTORY—S. 2195 (H.R. 3866):

HOUSE REPORTS: No. 108–461, Pt. 1 (Comm. on the Judiciary) and Pt. 2 (Comm.

on Energy and Commerce), both accompanying H.R. 3866.

CONGRESSIONAL RECORD, Vol. 150 (2004):

Oct. 6, considered and passed Senate.

Oct. 8, considered and passed House.

Æ

(b) A

to be appropriated to carry out this section, $1,000,000 for each

of fiscal years 2005 through 2010.

Approved October 22, 2004.

Related Articles:

Discuss this on bodybuilding forum

Post Footer automatically generated by Add Post Footer Plugin for wordpress.

en.pdf24.org    Send article as PDF   

One Comment »

  • Disney Pin Trading said:

    This website is seriously interesting, keep putting up good material.

Leave your response!

Add your comment below, or trackback from your own site. You can also subscribe to these comments via RSS.

Be nice. Keep it clean. Stay on topic. No spam.

You can use these tags:
<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

This is a Gravatar-enabled weblog. To get your own globally-recognized-avatar, please register at Gravatar.

Subscribe without commenting

IronMagazine Top Bodybuilding & Fitness Websites Submit Blog & RSS Feeds Hier gehts zur Topliste